search
Back to results

Effectiveness of Integrative and Complementary Practice in Health as a Strategy in Obesity Treatment

Primary Purpose

Obesity, Weight Loss

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Control Group
Auriculotherapy Group
Placebo group
Sponsored by
University of Pernambuco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Obesity, Auriculotherapy, Weight Loss, Nutrition Therapy

Eligibility Criteria

20 Years - 44 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Obesity
  • Body Mass Index: > 29,9kg/m²

Exclusion Criteria:

  • Pregnant women
  • Patients with treatment secondary
  • Need previous treatment for hormonal control
  • Have not properly completed or signed the informed consent form

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Other

    Active Comparator

    Placebo Comparator

    Arm Label

    Control Group

    Auriculotherapy Group

    Placebo group

    Arm Description

    Will receive individualized dietary plan - alimentary reeducation and micropore containing a point made with a black gel pen that will be placed in the ear

    Will receive individualized diet plan - diet reeducation and auricular therapy method with strategic points for obesity

    Will receive individualized diet plan - diet reeducation and sham points, points not indicative for the proposed treatment

    Outcomes

    Primary Outcome Measures

    Weight loss
    Weight loss will be verified by means of kilogram (kg)
    Abdominal circumferece
    Will be measured by the abdominal circumference measured in centimeters (cm)
    Cardiovascular risk
    The waist circumference in centimeters (cm) will be used to assess the decrease in cardiovascular risk, considering the cutoff points of the world health organization. Men -Increased ≥ 94 cm; Substantially increased ≥ 102cm. Woman - Increased ≥ 80 cm; Substantially increased ≥ 88cm.
    Height
    The height measured shall be taken to the extent of centimeters (cm)
    Body Max Index
    Body Mass Index (BMI) will be evaluated from weight (kg) and height (m) using the formula (kg/ m²).

    Secondary Outcome Measures

    Full Information

    First Posted
    September 11, 2019
    Last Updated
    September 12, 2019
    Sponsor
    University of Pernambuco
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04089384
    Brief Title
    Effectiveness of Integrative and Complementary Practice in Health as a Strategy in Obesity Treatment
    Official Title
    Effectiveness of Integrative and Complementary Practice in Health as a Strategy in Obesity Treatment
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 1, 2020 (Anticipated)
    Primary Completion Date
    September 1, 2020 (Anticipated)
    Study Completion Date
    December 30, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Pernambuco

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Obesity is highlighted, pointed as a disease that has been increasingly affecting individuals and becoming an epidemic in recent decades, but auriculotherapy has been shown to contribute to the treatment of this disease.The objective of this study was to evaluate the therapeutic efficacy of auriculotherapy associated with dietary education in reducing weight in obese patients. This is a simple-blind Randomized Clinical Trial.
    Detailed Description
    Considering the low cost, benefits and applicability of auriculotherapy in the integral care of the individual, as well as the remaining gap regarding studies involving the practice of auriculotherapy in obese patients with a representative sample, this study will be conducted with The objective of this study was to evaluate the therapeutic efficacy of auriculotherapy associated with dietary education in reducing weight in obese patients. The study will be performed at the nutrition laboratory III of the University of Pernambuco (UPE) Petrolina campus, with users previously diagnosed with obesity. This is a simple-blind Randomized Clinical Trial, with 3 groups: control group (will receive individualized dietary plan - alimentary reeducation and micropore containing a point made with a black gel pen that will be placed in the ear); auriculotherapy group (will receive individualized diet plan - diet reeducation and auricular therapy method with strategic points for obesity) and placebo group (will receive individualized diet plan - diet reeducation and sham points, points not indicative for the proposed treatment). Will be included in the study all adult patients of both sexes in the age of 20 years complete for 44 incomplete years, who meet the eligibility criteria. - Inclusion criteria: All adult patients seeking treatment for weight loss in August 2019 at the UPE and who agree to participate in the study by signing the Informed Consent Form (ICF). - Exclusion criteria: Pregnant women, patients who are treated with obesity secondary to some pathology and need previous treatment for hormonal control, or have not properly completed or signed the informed consent form. The sample size was estimated by the EPI INFO software, version 3.5.1. For the calculation it was considered that 20% of adults are obese and 30% have adequate nutritional status, assuming a relative risk of 1.5 to be obese, for a significance level of 95% (1-alpha) and a power value. 80% (1-alpha) with the ratio of unexposed / exposed being 1: 1. . The estimated value of the sample was 36 adults in each group, and the total sample 108, adding 10% in each group to compensate for any losses, resulted in a final sample of 120 individuals, with no 40 participants per group. Randomization will be performed near the beginning of the intervention by a researcher not involved in the study using the Epitable application's random number table from the EPI-INFO software. The codes that will define which group the recruited obese patients (Control group, auriculotherapy or placebo) will belong to will be placed in opaque envelopes and sealed by one of the researchers who will not be involved in opening them, and upon recruitment, will be opened by the research assistant, who will register the patients, following the sequence of the drawn envelopes. :

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obesity, Weight Loss
    Keywords
    Obesity, Auriculotherapy, Weight Loss, Nutrition Therapy

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    All patients selected for the research will be interviewed by the same Nutritionist, responsible for the anthropometric assessment, who will use a specific questionnaire to record the personal, socioeconomic and lifestyle information of the patients. A. Control Group: Patients in this group will receive an individualized eating plan every 15 days and a marked micropore. B. Auriculotherapy group: will receive individualized eating plan every 15 days and will undergo 12 auriculotherapy sessions, 1 per week, lasting 5 to 10 minutes for each session, will be compressed by mustard seed in the following points; mouth, stomach, anxiety, hunger and Shen Men. C. Placebo group: will receive individualized eating plan every 15 days and will undergo 12 auriculotherapy sessions, similar to the auriculotherapy group, but the applications will be in sham points, points not indicative for the proposed treatment, wrist and outer ear points.
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    120 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Control Group
    Arm Type
    Other
    Arm Description
    Will receive individualized dietary plan - alimentary reeducation and micropore containing a point made with a black gel pen that will be placed in the ear
    Arm Title
    Auriculotherapy Group
    Arm Type
    Active Comparator
    Arm Description
    Will receive individualized diet plan - diet reeducation and auricular therapy method with strategic points for obesity
    Arm Title
    Placebo group
    Arm Type
    Placebo Comparator
    Arm Description
    Will receive individualized diet plan - diet reeducation and sham points, points not indicative for the proposed treatment
    Intervention Type
    Other
    Intervention Name(s)
    Control Group
    Intervention Description
    Will receive individualized dietary plan - alimentary reeducation and micropore containing a point made with a black gel pen that will be placed in the ear
    Intervention Type
    Other
    Intervention Name(s)
    Auriculotherapy Group
    Intervention Description
    Will receive individualized diet plan - diet reeducation and auricular therapy method with strategic points for obesity
    Intervention Type
    Other
    Intervention Name(s)
    Placebo group
    Intervention Description
    Will receive individualized diet plan - diet reeducation and sham points, points not indicative for the proposed treatment).
    Primary Outcome Measure Information:
    Title
    Weight loss
    Description
    Weight loss will be verified by means of kilogram (kg)
    Time Frame
    12 weeks
    Title
    Abdominal circumferece
    Description
    Will be measured by the abdominal circumference measured in centimeters (cm)
    Time Frame
    12 weeks
    Title
    Cardiovascular risk
    Description
    The waist circumference in centimeters (cm) will be used to assess the decrease in cardiovascular risk, considering the cutoff points of the world health organization. Men -Increased ≥ 94 cm; Substantially increased ≥ 102cm. Woman - Increased ≥ 80 cm; Substantially increased ≥ 88cm.
    Time Frame
    12 weeks
    Title
    Height
    Description
    The height measured shall be taken to the extent of centimeters (cm)
    Time Frame
    12 weeks
    Title
    Body Max Index
    Description
    Body Mass Index (BMI) will be evaluated from weight (kg) and height (m) using the formula (kg/ m²).
    Time Frame
    12 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    44 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Obesity Body Mass Index: > 29,9kg/m² Exclusion Criteria: Pregnant women Patients with treatment secondary Need previous treatment for hormonal control Have not properly completed or signed the informed consent form
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Cicero Jonas R. Benjamim
    Phone
    5588997290435
    Email
    jonasbenjam1m@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Alessandra Galdino
    Organizational Affiliation
    University of Pernambuco
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Andrea Sotero, phD
    Organizational Affiliation
    University of Pernambuco
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effectiveness of Integrative and Complementary Practice in Health as a Strategy in Obesity Treatment

    We'll reach out to this number within 24 hrs